Terbinafine: Mode of action and properties of the squalene epoxidase inhibition

Terbinafine (Lamisil®) has primary fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition. Treated fungi accumulate squalene while becoming deficient in ergosterol, an essential component of fungal cell membranes. The cidal action is closely associated with the development of high intracellular squalene concentrations, which are believed to interfere with fungal membrane function and cell wall synthesis. In the case of Candida albicans, growth inhibition with terbinafine appears to result from the ergosterol deficiency. The filamentous form of this fungus is more susceptible than the yeast form. Measurement of ergosterol biosynthesis by incorporation of radiolabelled precursors indicates a correlation between inhibition of growth and ergosterol biosynthesis in a range of pathogenic fungi. Terbinafine is a potent non‐competitive inhibitor of squalene epoxidase from Candida (Ki=30nm). In constrast, inhibition of rat liver squalene epoxidase only occurs at higher drug concentrations (Ki=77 μm), and is competitive with squalene. Thus, terbinafine has no effect on cholesterol biosynthesis in vivo. Squalene epoxidase is not an enzyme of the cytochrome P‐450 type, thereby avoiding potential inhibition of this class of enzymes.

[1]  N. Ryder The mechanism of action of terbinafine , 1989, Clinical and experimental dermatology.

[2]  J Drews,et al.  In vitro activity of naftifine, a new antifungal agent , 1981, Antimicrobial Agents and Chemotherapy.

[3]  N. Ryder Mechanism of action of the allylamine antimycotics , 1987 .

[4]  U. Sleytr,et al.  Morphological changes induced by Naftifine, a new antifungal agent, in Trichophyton mentagrophytes. , 1981, The Journal of investigative dermatology.

[5]  N S Ryder,et al.  Properties of a particulate squalene epoxidase from Candida albicans. , 1984, Biochimica et biophysica acta.

[6]  N. Ryder,et al.  Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans , 1984, Antimicrobial Agents and Chemotherapy.

[7]  G. Petrányi,et al.  Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.

[8]  D. Back,et al.  Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. , 1989, British journal of clinical pharmacology.

[9]  R. S. Burden,et al.  The lipid compositions of two isolates of Cladosporium cucumerinum do not explain their differences in sensitivity to fungicides which inhibit sterol biosynthesis , 1989 .

[10]  I. Schuster The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  N. Ryder Mechanism of Action and Biochemical Selectivity of Allylamine Antimycotic Agents , 1988, Annals of the New York Academy of Sciences.

[12]  N. Ryder Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic. , 1990, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[13]  N. Ryder Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent , 1985, Antimicrobial Agents and Chemotherapy.

[14]  N S Ryder,et al.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. , 1984, Science.

[15]  N. Ryder Squalene Epoxidase — Enzymology and Inhibition , 1990 .

[16]  N. Ryder Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. , 1985, Journal of General Microbiology.

[17]  A. Stütz Synthesis and Structure‐ Activity Correlations within Allylamine Antimycotics , 1988, Annals of the New York Academy of Sciences.

[18]  N. Ryder Squalene epoxidase as a target for the allylamines. , 1991, Biochemical Society transactions.

[19]  N. Ryder Squalene epoxidase as the target of antifungal allylamines , 1987 .

[20]  E. Mercer,et al.  Location of squalene accumulation and physiological effects of ergosterol depletion in naftifine-grown yeast , 1988 .

[21]  N S Ryder,et al.  Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes. , 1985, The Biochemical journal.

[22]  M. Schaude,et al.  Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicans , 1987, Mykosen.

[23]  P. Leroux,et al.  Resistance to inhibitors of sterol biosynthesis in field isolates or laboratory strains of the eyespot pathogen Pseudocercosporella herpotrichoides , 1988 .

[24]  N. Ryder,et al.  Allylamine antifungal drugs. , 1992, Current topics in medical mycology.